Skip to main content
English homeNews home
Story

Grifols reaffirms guidance for 2025

Grifols (GRFS) said: “Grifols remains focused on the continued execution of its strategic plan and reaffirms its guidance for FY2025. Due to the impact of the Inflation Reduction Act on its financial results, Grifols expects to share greater detail in 2025 giving investors and analysts further visibility on its actual performance and underlying momentum. As a result, for 2025, Grifols expects to show both reported figures and LFL figures to make them comparable to previous quarters. LFL figures adjust for the impact on Biopharma performance of both the Inflation Reduction Act Medicare Part D Redesign and the Fee-for-Services reclassification in Q4’24.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas" href="https://thefly.com/?utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">Try Now>>

>;elm:context_link;itc:0;sec:content-canvas" href="https://www.tipranks.com/screener/analysts-top-stocks/?type=stockAnalysisLanding&utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">See the top stocks recommended by analysts >>

Read More on GRFS:

Disclaimer & DisclosureReport an Issue

Terms and Privacy Policy

Recommended Stories

Sabra Health Care price target raised to $19 from $18 at Scotiabank

UDR price target raised to $51 from $49 at Scotiabank

Cineverse announces formation of Cineverse Motion Pictures Group

Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year

Schneider Electric downgraded to Equal Weight from Overweight at Barclays

Chegg to lay off 22% of its workforce

Wartsila, Megatugs join forces to enhance underwater shipping services

How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings

Signal: Foot Locker Stock Rally Might Not Last